We are pleased to announce that the European Medicines Agency will be hosting a virtual Regulatory and scientific conference on RNA-based medicines on 2 February 2023.
The aim of the conference is to promote the development of RNA-based medicines by:
- Identifying scientific and regulatory opportunities and challenges of RNA-based innovative medicines.
- Facilitating dialogue between industry/academia and regulators and raising awareness on scientific and regulatory aspects.
- Identifying gaps in regulatory science.
The conference focuses on emerging RNA technologies beyond vaccines. Please see the programme posted in the EMA website for more details.
The event will be broadcast and recorded and is open to all stakeholders. Please register on the EMA website for active participation.
The videos and presentations will be made available on the EMA website.
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
